Healthcare (Prescription Drugs)

in committee · New York · Assembly May 4, 2026

A 11256: Requires health plan coverage to include certain generic drugs and biosimilars

Requires health plan coverage to include generic drugs and biosimilars where the wholesale acquisition cost of such generic drugs or biosimilars is lower than the brand drug's wholesale acquisition cost.

Topics ✓ HealthcareSupports HealthcareBill mandates coverage for lower-cost generic drugs and biosimilars, expanding access and reducing patient costs.95% confidence

Sub-Topics Insurance Prescription Drugs

Track

in committee · New York · Assembly Apr 8, 2026

A 10873: Relates to peripheral artery disease

This bill mandates that health insurance policies in the state cover treatment for peripheral artery disease, a condition affecting blood flow to the limbs. It specifically requires coverage for individuals with comprehensive medical plans and prescription drug benefits, including those held by medical expense indemnity corporations and health service corporations. The law applies to all policies issued, renewed, or modified on or after January 1, 2027, ensuring that new and existing contracts meet this requirement.

Topics ✓ HealthcareSupports HealthcareBill mandates insurance coverage for peripheral artery disease treatment, expanding access and protecting patient rights.95% confidence

Sub-Topics Insurance Prescription Drugs

Track

in committee · New York · Senate May 11, 2026

S 10278: Relates to the practice of pharmacy and administration of immunizations

This bill allows licensed pharmacists to administer flu shots to individuals who are nine years old or older. It achieves this by adding a new provision to the state's education law that explicitly grants pharmacists this authority. The law will not take effect immediately but will begin ninety days after it is officially signed into law. This change aims to increase access to flu vaccinations by expanding the range of healthcare professionals who can provide them.

Topics ✓ HealthcareSupports HealthcareBill expands access to flu vaccinations by allowing pharmacists to administer them, improving patient care.95% confidence

Sub-Topics Prescription Drugs

Track

in committee · New York · Senate Jun 5, 2026

S 9651: Relates to utilization review program standards and pre-authorization for certain health care services

Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.

Topics ✓ HealthcareSupports HealthcareBill mandates evidence-based and peer-reviewed criteria for utilization review, improving care quality and protecting patient rights.85% confidence

Sub-Topics Prescription Drugs

Track

in committee · New York · Senate Apr 21, 2026

S 9985: Enhances transparency in the prescription drug supply chain

Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.

Topics ✓ HealthcareSupports HealthcareBill enhances transparency in the prescription drug supply chain, improving patient access to information and protecting patient rights.85% confidence

Sub-Topics Prescription Drugs

Track

in committee · New York · Assembly Apr 14, 2026

A 10967: Enhances transparency in the prescription drug supply chain

Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.

Topics ✓ HealthcareSupports HealthcareBill enhances transparency in the prescription drug supply chain, improving patient access to information and protecting patient rights.85% confidence

Sub-Topics Prescription Drugs

Track

passed · New York · Senate May 11, 2026

S 9331: Relates to access to prescription medication and coordination with workers' compensation board regulations governing network pharmacy use

Codifies certain regulations of the workers' compensation board relating to access to prescription medication and coordination with workers' compensation board regulations governing network pharmacy use; requires the workers' compensation board to file a report on out-of-network pharmacy use within 3 years of the effective date.

Topics ✓ HealthcareSupports HealthcareBill improves patient access to prescription medications by codifying workers' compensation regulations and requiring reporting on out-of-network pharmacy use.85% confidence

Sub-Topics Prescription Drugs

Track

in committee · New York · Senate May 13, 2026

S 9401: Requires the department of health to facilitate the exchange of data between the state prescription drug program and electronic health records

Directs the commissioner of health shall promulgate regulations allowing for any electronic health records integration vendor to obtain state approval to facilitate interoperability between the prescription monitoring program registry and certified electronic health records systems that can connect with any national data sharing hub.

Topics ✓ HealthcareSupports HealthcareBill improves healthcare interoperability by enabling data exchange between prescription programs and electronic health records, enhancing patient care coordination and safety.85% confidence ✓ TechnologySupports TechnologyBill promotes interoperability between health data systems and electronic health records, enhancing digital health infrastructure and data exchange capabilities.75% confidence

Sub-Topics Prescription Drugs

Track

in committee · New York · Senate Jun 1, 2026

S 9497: Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug

Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.

Topics ✓ HealthcareSupports HealthcareBill requires insurers to cover brand name drugs during generic shortages, improving patient access to necessary medications and protecting healthcare continuity.90% confidence

Sub-Topics Prescription Drugs

Track

in committee · New York · Assembly May 12, 2026

A 10413: Relates to access to prescription medication and coordination with workers' compensation board regulations governing network pharmacy use

Codifies certain regulations of the workers' compensation board relating to access to prescription medication and coordination with workers' compensation board regulations governing network pharmacy use; requires the workers' compensation board to file a report on out-of-network pharmacy use within 3 years of the effective date.

Topics ✓ HealthcareSupports HealthcareBill improves patient access to prescription medication by codifying regulations and requiring reporting on out-of-network pharmacy use, enhancing healthcare coordination.75% confidence

Sub-Topics Prescription Drugs

Track